Conditions Treated Patient Education About the Institute About Dr. Dell FAQs Contacts & Directions
About Dr. Dell Contacts & Directions Referring Physicians

Jeffrey R. Dell, MD, FACOG, FACS

Medical Licensure:                           Tennessee, MD25063, Issued: November, 1993

 

Board Certification:                           American Board of Obstetrics and Gynecology,

                                                            November 20,1998

 

Society Membership:                        Fellow, American College of Obstetrics & Gynecology

                                                            Fellow, American College of Surgeons

                                                            East Tennessee Ob/Gyn Society

                                                            Society of Pelvic Reconstructive Surgeons

                                                            American Association of Gynecologic Laparoscopists

                                                            American Urogynecologic Society

 

Visiting Professor Program:             Urogynecology and Pelvic Reconstructive Surgery

                                                           Wyeth-Ayerst Pharmaceuticals

                                                           1998-Present

 

Overactive Bladder Council:            Speaker

                                                           University of Wisconsin-Madison

 

Reconstructive Pelvic Surgery:        Core Faculty

                                                            MDU Surgical Training Program

 

Director of Surgical Preceptorship

                                                            C.R. Bard Urology

Pelvic Floor Reconstruction and Female Incontinence

 

Director of Local TVT Training Program

Gyncecare, Ethicon Inc.

 

Director of Local Surgical Preceptorship

American Medical Systems

     

                                                            Research and Product Development Consultant

                                                            C. R. Bard Urology

 

                                                            Research and Product Development Consultant

                                                            Gynecare, Ethicon Inc.

 

                                                            Product Development Consultant

                                                            American Medical Systems

 

Bard Contigen Injection                  

Program:                                            Preceptor, 1999 – Present

 

Bard Tegress™ Implant:                  Preceptor, 2005 – Present

                                                            Steering Committee Member

                                                            National Faculty Member

                                                            Lead Investigator:  5 – year

                                                            Multi-Center – Post Approval Registry Study

 

Scientific Advisory Board:               Physicians Nutraceutical Laboratories, Inc.

 

Physician Editorial Advisory

Panel:                                                 OBG Management

 

Professional Advisory

Committee:                                        Girling Health Care, Inc.

 

Ortho-McNeil Pharmaceutical:       

 -Gynecological Working Group for Chronic Pelvic Pain

  and Interstitial Cystitis

-Site Director for Multi Center, randomized,double-blind,

  Placebo controlled Elmiron Study

                                    -Elmiron National Speaker Bureau

                                                            -Ditropan XL National Speaker Bureau

                                    -Elmiron National Advisory Board Member

                                                            -National Steering Committee Member – Bladder Matters:

                                                              Clinical Insights on Urologic Health

 

 

Strathmore’s Who’s Who:               Honors Recipient

 

Residency:                                          Obstetrics and Gynecology

University of Tennessee, Memphis

July 1993-June 1996

 

Internship:                                         Obstetrics and Gynecology

University of Tennessee, Memphis

June 1992 -June 1993

 

Medical:                                             University of Minnesota School of Medicine

Minneapolis, MN

M.D. June 1992

 

Honors:                                              Fulbright-Swyers Academic Scholarship Recipient 1988-1992

Phi Rho Sigma Medical Fraternity, Member and Officer

MATEC-Midwest Aids Training –Speaker and Representative

DOC-Doctors Ought to Care, Speaker to Metro Area High

School Students

Guest Lecturer, at Baptist Bible College, Springfield MO.

1990-1991 Topics: AIDS, Genetics, Right to Die-issues

 

Undergraduate:                                 Southwest Missouri State University, Springfield, MO

Bachelor of Science, Summa Cum Laude

Major: Chemistry, Minor: Biology, Graduated 1988

 

Honors:                                              Chemistry Honor Society

Pre-medical Society-President

Student Advisory Council

Outstanding Organic Chemistry Student Award

Outstanding Biochemistry Student Award

Outstanding Physical Chemistry Student Award

Smith-Glynn Callaway Outstanding Junior Pre-Med Scholarship recipient

Chemistry Department Scholarship recipient

Regents Academic Scholarship recipient

 

High School:                                      Owatonna High School, Owatonna, Minnesota

Graduated 1983

 

Abstracts Published/Papers Presented:

  1. Sarinoglu C, Dell JR, Sibai BM, Mercer B: Fetal Startle Response Observed Under Ultrasonography Predicts a Reassuring Biophysical Profile. 15th Annual Meeting of the Society of Perinatal Obstetricians, Atlanta, Georgia, January 1995, abst#284.
  2. Sarinoglu C, Dell JR, Ling F, Sibai BM, Mercer B: Fetal Startle Response Observed Under Ultrasonography Predicts a Reassuring Biophysical Profile. I 1996, 88:599-602.
  3. Lipscomb G, Dell JR, Ling F, Spellman J: A Comparison of the Cost of Local Versus General Anesthesia for Laparoscopic Sterilization in an Operating Room Setting. Presented at the Annual Clinical Meeting of the American College of Obstetricians and Gynecologists, San Francisco, CA May 8-9,1995.
  4. Lipscomb G, Dell JR, Ling F, Spellman J: A Comparison of the Cost of Local Versus General Anesthesia for Laparoscopic Sterilization in an operating Room Setting, Journal of American Association of Gynecologic Laparoscopy, Vol. 3, No 2: 277-281, 1996.
  5. Dell JR: Persistent Sinus Tract Following Abdominal Scarocolopexy with Synthetic Mesh, J Pelvic Surg. 7: 301, 2001.
  6. Parsons CL, Dell JR, Stanford EJ, et al: Increased Prevalence of Interstitial Cystitis: Previously Unrecognized Urologic and Gynecologic Cases Identified using a New Symptom Questionnaire and Intravesical Potassium Sensitivity. Urology 60 (40); 573 – 578, 2002. [ downloadPDF]
  7. Parsons CL, Dell JR, Bullen M, et al: Increased Prevalence of Interstitial Cystitis in Urologic Patients and Gynecologic Pelvic Pain Patients as Determined Using a New Symptom Questionnaire. J Urol 167 (Suppl); 65, 2002.
  8. Parsons CL, Dell J, Stanford EJ, et al: The Prevalence of Interstitial Cystitis in Gynecologic Patients with Pelvic Pain as Detected by Intravesical Potassium Sensitivity. Am J Obstet Gynecol 187: 1395 – 1400, 2002.
  9. Moldwin RM, Dell JR: The Evaluation and Treatment of Interstitial Cystitis. The Female Patient . June 2003; (suppl) 19 – 26.
  10. Moldwin R, Dell J: Evaluating and Treating Interstitial Cystitis An Introduction. Women’s Health Care 2003; 2: 7.
  11. Moldwin R, Dell J: Female Chronic Pelvic Pain. Women’s Health Care 2003; 2: 8 – 11.
  12. Moldwin R, Dell J: Interstitial Cystitis: Causes and Consequences. Women’s Health Care 2003; 2: 12 – 14.
  13. Moldwin R, Dell J: Diagnosis of Interstitial Cystitis. Women’s Health Care 2003; 2: 17 – 21.
  14. Moldwin R, Dell J: Interstitial Cystitis: Summary, Guidelines, and Special Concerns. Women’s Health Care 2003; 2: 30 – 34.
  15. Dell JR: Potassium Sensitivity Test. The Female Patient. June 2003; (suppl) 27 – 30.
  16. Dell JR: Chronic Pelvic Pain of Bladder Origin: A Focus on Interstitial Cystitis. Presented at the Annual Clinical meeting of The World Foundation for Medial Studies in Female Health. Kansas City, KS. April 10 – 12, 2003.
  17. Dell JR: Chronic Pelvic Pain of Bladder Origin: A Focus on Interstitial Cystitis. Int J Fertil 2003; 48(4): 154 – 162. [ downloadPDF]
  18. Dell JR: Building a Successful Interstitial Cystitis Practice in Gynecology.Practice Building Today September 2003; 4 – 11.
  19. Moldwin RM, Dell JR: Chronic Pelvic Pain of Bladder Origin: A Clinician’s Handbook on the Evaluation and Treatment of Interstitial Cystitis.© 2003; Synermed Communications
  20. Dell JR: Chronic Pelvic Pain of Bladder Origin: A Focus on Interstitial Cystitis. Clinical Courier September 2003; Vol. 21, No. 30.
  21. Dell JR: Treatment of Overactive Bladder to Improve Your Patient’s Quality of Life: Pelvic and Bladder Health in the Continuum of Care. October 2003; Vol. 1, Issue 1.
  22. Dell JR: Pelvic Care: Diagnosis and Treatment of Overactive Bladder. Pelvic and Bladder Health in the Continuum of Care. December 2003; Vol. 1, Issue 2.
  23. Dell JR: Treating Overactive Bladder and Managing Reimbursement Issues. Pelvic and Bladder Health in the Continuum of Care. January 2004; Vol. 1, Issue 3.
  24. Dell JR, Shulman LP: Chronic Pelvic Pain (CPP) of Bladder Origin: A Focus on Interstitial Cystitis (IC). Clinician October 2003; Vol. 21, No. 10.
  25. Dell JR, Parson CL: Intravesical Instillation Therapy Using PPS in Patients with Interstitial Cystitis. Poster 18. Presented at: Research Insights into Interstitial Cystitis: A Basic and Clinical Science Symposium. October 30 – November 1, 2003; Alexandria, Virginia.
  26. Dell JR: Use of the PUF Questionnaire to Determine the Prevalence of Interstitial Cystitis in Obstetrics and Gynecology Practices. Poster 19. Presented at: Research Insights into Interstitial Cystitis: A Basic and Clinical Science Symposium. October 30 – November 1, 2003; Alexandria, Virginia.
  27. Stanford EJ, Parsons CL, Dell JR, et al: Characteristics of Gynecologic Patients Enrolled in Double-Blind Study of Pentosan Polysulfate Sodium (PPS, Elmiron) Therapy for Chronic Pelvic Pain. Poster 49. Presented at: Research Insights into Interstitial Cystitis: A Basic and Clinical Science Symposium. October 30 – November 1, 2003; Alexandria, Virginia.
  28. Dell JR, Shulman LP: Chronic Pelvic Pain (CPP) of Bladder Origin: A Focus on Interstitial Cystitis (IC). A Nationwide Teleconference Series. July 2003 – March 2004. Dannemiller Memorial Educational Foundation and Synermed Communications.
  29. Dell JR, Parsons CL: Multimodal Therapy for Interstitial Cystitis. J Reprod Med 2004; 49: 243 – 252.
  30. Dell, JR: Site-Specific Rectocele Repair Augmented with Pelvisoft™ Biomesh. A Surgical Video. ©2003; C.R. Bard Inc.
  31. Grochmal, SA, Dell, JR, Sherry SJ: Prevalence of Bladder Origin Pain (Interstitial Cystitis) in Adolescent Women with Failed Treatment for Documented Endometriosis. Poster 31. Presented at: The 5th World Congress on Controversies in Obstetrics and Gynecology. June 3 – 6, 3004; Las Vegas, Nevada.
  32. Mishell DR, Dell, JR: Chronic Pelvic Pain of Bladder Origin: A Focus on Interstitial Cystitis. OB GYN Rounds May 2004; Vol. 4, No. 2.
  33. Dell JR, O’Kelley, KR: Pelvisoft Biomesh Augmentation of Rectocele Repair: The Initial Clinical Experience in 35 Patients. Int Urogynecol J 2005; 16: 44 – 47. [ downloadPDF]
  34. Dell, JR: Understanding Chronic Pelvic Pain in Women: Diagnosing and Managing Women with Interstitial Cystitis. The Female Patient September 2004; Vol. 29, No. 5.
  35. Dell JR, O’Kelley KR: TVT Erosion Secondary to a Twist in Tape. Int Urogynecol J 2005; 16: 168 – 169.
  36. Dell JR, Mishell DR, Shulman LP: Chronic Pelvic Pain (CPP) of Bladder Origin: A Focus on Interstitial Cystitis (IC). A Nationwide Teleconference Series. May 2004 – September 2004. Dannemiller Memorial Educational Foundation and Synermed Communications.
  37. Dell JR, O’Kelley KR: Pelvisoft Biomesh Augmentation of Rectocele Repair: The Initial Clinical Experience in 35 Patients. Presented at: Joint Meeting of the International Continence Society and the International Urogynecological Association. August 23 – 27, 2004; Paris, France.
  38. Dell JR, O’Kelley KR: Pelvisoft Biomesh Augmentation of Rectocele Repair: The Initial Clinical Experience in 35 Patients. Presented at: The Global Congress of Gynecologic Edoscopy, AAGL 33rd Annual Meeting. November 10 – 13, 2004; San Francisco, California.
  39. Dell JR, Groshmal SA: Intravesical Therapy for the Treatment of Interstitial Cystitis Using a Therapeutic Cocktail. Poster 188. Presented at: The Global Congress of Gynecologic Endoscopy, AAGL 33rd Annual Meeting. November 10 – 13, 2004; San Francisco, California.
  40. Wysocki S, Dell JR, Smith D: Use of the PUF questionnaire to determine the prevalence of interstitial cystitis among nurse practitioners. Presented at: NPWH 7th Annual Conference: Women’s Health Care in the New Millennium. October 13 – 16, 2004. Chicago, IL.
  41. Dell JR. Intravesical Therapy for the Treatment of Interstitial Cystitis using a Therapeutic Cocktail. The Journal of the American Association of Gynecologic Laparosopists. August 2004; Vol. 11, No 3 (suppl). [ downloadPDF]
  42. Dell JR. Understanding Chronic Pelvic Pain in Women: Diagnosing and Managing Women with Interstitial Cystitis. The Female Patient . (suppl) October 2004.
  43. Mishell DR, Dell JR: Chronic Pelvic Pain of Bladder Origin: Interstitial Cystitis. Obstetrics and Gynecology Board Review Manual. Hospital Physician. December 2004; Vol. 9, Part 4.
  44. Dell JR, Fourcroy JL, Smith D: Understanding Interstitial Cystitis. Clinical Courier. February 2005; Vol. 23, No. 4.
  45. Dell JR, Fourcroy JL, Smith D: Understanding Interstitial Cystitis: Case Studies. Clinical Courier. March 2005; Vol. 23, No. 20.
  46. Stanford C, Dell JR: Physician Satisfaction with the SPARCTM Suprapubic Sling System: An Opinion bases Survey. J Pelvic Medicine & Surgery. March/April 2005; Vol. 11, No. 2.
  47. Dell JR; Pharmacologic and Nonpharmacologic Treatment Options for Interstitial Cystitis. Adv Stud Pharm. 2005: 15 – 22.
  48. Wysocki S, Smith D, Dell J: Interstitial Cystitis: An Update and Results from the NPWH’s IC Prevalence Survery. Women’s HealthCare. July 2005; Vol. 4, No. 4, 28 – 38.
  49. Dell JR, O’Kelley KR: Pelvisoft Biomesh augmentation of rectocele repair – initial clinical experience. Issues in Women’s Health. 2005; Vol. 2, No. 1, 14 – 17.
  50. Dell JR: An Interview with Jeffrey R. Dell, M.D. Journal of Gynecologic Surgery. 2005; Vol. 21, No. 4.
    [ downloadPDF]
  51. Dell JR, Butrick CW: Multimodal Therapy for Painful Bladder Syndrome / Interstitial Cystitis. J Reprod Med (Suppl). March 2006; Vol. 51, No. 3: 253 – 260. [ downloadPDF]
  52. Stanford EJ, Dell JR, Parsons CL. The Emerging Presence of Interstitial Cystitis in Gynecologic Patients with Chronic Pelvic Pain. Urology. 2007; 69 (Suppl 4A): 53 – 59. [ downloadPDF]
  53. Forrest JB, Dell JR. Successful Management of Interstitial Cystitis in Clinical Practice. Urology. 2007; 69 (Suppl 4A): 82 – 86.
  54. Dell JR. Year Book of Obstetrics, Gynecology and Women’s Health. Contributing Editor – Chapter 31 – Urogynecology. Elsevier. 2007.

Ongoing Research Activity:

  1. Parsons CL, Dell JR, Bullen M, et el: The Prevalence of Interstitial Cystitis in Gynecological Patients with Pelvic Pain As Detected by Intravesical Potassium Sensitivity. Study Completed. Publication Pending.
  2. Parsons CL, Dell JR, Evans R, Teichman J: A Multi-Center Parallel Trial of Potassium Sensitivity Testing in Interstitial Cystitis Patients and Healthy Asymptomatic Controls. Study in progress.
  3. Parson CL, Bullen M, Dell JR, et al:Identifying Bladder Origin Pelvic Pain/Interstitial Cystitis in Gynecologic Patients and Their Treatment with Pentosan Polysulfate vs. Placebo. Study in progress.
  4. Efficacy and Safety of Duloxetine Compared with Placebo in Women with Symptoms of Mixed Urinary Incontinence. Study completed.
  5. Effect of Duloxetine on Valsalva Leak Point Pressure and Quantitative Rhabdosphincter Electromyography Measures in Women with Stress Urinary Incontinence. Study completed.
  6. Tegress™ Post-approval Registry Assessment of Long-term Safety and Effectiveness in Female Patients Treated with Tegress™ for Stress Urinary Incontinence. Study in progress.

 

 Personal Data:

 

Birthplace:       Minneapolis, Minnesota

Wife:               Kelly

Children:         Morgen

                      Garrison
                                Dawson